13F Pro quality score
Rank #2,590 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from Bioceres Crop Solutions Corp.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 20-F | $335.1M | $-55.4M | -0.7% |
| FY 2024 | 20-F | $464.8M | $4.3M | 9.9% |
| FY 2023 | 20-F | $420.1M | $18.8M | 12.9% |
| FY 2022 | 20-F | $334.8M | $-7.2M | 11.9% |
| FY 2021 | 20-F | $209.5M | $-6.9M | 18.3% |
| FY 2020 | 20-F | $173.1M | $3.4M | 22.6% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
Bioceres Crop Solutions Corp. (BIOX) stock profile, AI quality score, and SEC EDGAR financial data, a Materials sector company. 13F Pro's AI-powered ranking engine scores BIOX at 26.5/100 on a composite quality score built from its SEC filings, placing it at rank #2,590 of 2,925 stocks — the bottom half of the AI-ranked universe. BIOX scores in the top quartile across free cash flow (80.8). Areas of concern include revenue growth (4.1) and institutional flow (4.4), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Bioceres Crop Solutions Corp. reports quarterly revenue of $65.3M, net income of $-182.5M, an operating margin of 15.3%. Top institutional holders of BIOX by reported 13-F value include Solel Partners, MIRAE ASSET GLOBAL ETFS Ltd., Long Focus Capital Management, based on the most recent SEC filings. BIOX trades on the Nasdaq exchange and files with the SEC under CIK 1769484. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BIOX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bioceres Crop Solutions Corp. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1769484 →